Back to Trexquant Investment LP Trexquant Investment LP

EGRXEGRX
16 quarters

Position history for Trexquant Investment LPTrexquant Investment LP's holdings in EAGLE PHARMACEUTICALS INC

No. Trexquant Investment exited its EGRX (Eagle Pharmaceuticals) position in Q4 2024. Its Q3 2024 13F listed 43,723 shares worth $163,087. Trexquant Investment already held EGRX in its Q1 2019 13F, the earliest on record, and held it in 11 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$442,000

Total Shares Change

-8,753

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.50
0
2024-Q3
Decreased
43,723
-17.4%
$163,0870.0%$3.95
0
2024-Q2
Decreased
52,953
-40.8%
$296,5370.0%$5.60
0
2024-Q1
Decreased
89,442
-29.2%
$468,6760.0%$5.24
0
2023-Q4
Increased
126,282
+88.0%
$660,4550.0%$5.23
38
2023-Q3
Increased
67,187
+26.1%
$1.1M0.0%$15.77
31
2023-Q2
Increased
53,277
+251.5%
$1M0.0%$19.47
40
2023-Q1
New
15,158
-
$430,0320.0%$27.88
33
2021-Q2
Exited
0
-100.0%
$00.0%$42.14
0
2021-Q1
New
11,027
-
$460,0000.0%$41.06
33
2020-Q4
Exited
0
-100.0%
$00.0%$46.50
0
2020-Q3
New
18,954
-
$805,0000.1%$41.88
34
2020-Q2
Exited
0
-100.0%
$00.0%$48.02
0
2020-Q1
New
19,739
-
$908,0000.1%$45.31
34
2019-Q2
Exited
0
-100.0%
$00.0%$55.68
0
2019-Q1
First report
8,753
-
$442,0000.0%$50.49
0

Other major holders of EGRX: Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used